In patients with history of neutropenia in childhood and adolescence, information on the length and dose of granulocyte-colony stimulating factor (G-CSF) usage is helpful in the evaluation of a patient with new MDS, as it may suggest germline mutations associated with severe congenital neutropenia (SCN) due to germline ELANE mutations. This evidence concerns the gene CSF3 and myelodysplastic syndrome.